Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review,

Abstract Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytoki...

Full description

Bibliographic Details
Main Authors: Oriete Gerin Leite, Sandra Tagliolatto, Elemir Macedo de Souza, Maria Letícia Cintra
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2020-03-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000100063&tlng=en